Retraction: molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor i receptor inhibition
- PMID: 24928947
- PMCID: PMC4394839
- DOI: 10.1158/1078-0432.CCR-14-1118
Retraction: molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor i receptor inhibition
Retraction of
-
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.Clin Cancer Res. 2010 Sep 15;16(18):4654-65. doi: 10.1158/1078-0432.CCR-10-0089. Epub 2010 Jul 29. Clin Cancer Res. 2010. Retraction in: Clin Cancer Res. 2014 Jun 15;20(12):3358. doi: 10.1158/1078-0432.CCR-14-1118. PMID: 20670944 Free PMC article. Retracted.
References
-
- Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, et al. Phase II study of the anti–insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol. 2009;27:2516–22. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
